Alshehri, E. (2026) The Diagnostic Conundrum of Recurrent High-Grade Vaginal Intraepithelial Neoplasia (VAIN) Following ...
(RTTNews) - Merck & Co Inc. (MRK), Monday announced that Health Canada has approved KEYTRUDA in combination with cisplatin-based chemoradiotherapy for patients with FIGO 2014 Stage III-IVA cervical ...
Health Care Utilization and Follow-Up Care in Young Adult Breast Cancer Survivors We performed a nation-wide retrospective matched cohort study of all patients age 18-45 years with Fédération ...
Adjuvant chemoradiation with weekly cisplatin did not significantly improve survival outcomes — but did increase toxicities — compared with adjuvant radiotherapy alone in women with early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results